Tradestie Institutional Equity Comparison Engine

AADR vs APVO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

APVO Overall Edge

APVO Captures Institutional Edge (2โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aptevo Therapeutics Inc (APVO) driven by superior Valuation, Growth & Margin while AADR counters with relative strength in Momentum & Technical. Fundamentally, AADR trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus APVO at 3.9x Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, AADR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against APVO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner APVO
AADR N/M vs APVO 3.9x Fwd P/E
Growth & Margin Winner APVO
Op Margin N/A vs 0.0% ยท YoY N/A vs -100.0%
Momentum & Technical Winner AADR
1Y -9.7% vs -62.2% ยท 52W Pos 6% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AADR NASDAQ
AdvisorShares Dorsey Wright ADR ETF
Institutional Equity
$77.92
-1.77% 1D
Market Cap N/A
1M Return -2.99%
1Y Return -9.72%
Forward P/E N/M
Unified AI Score
57.7 / 100 HOLD
Tech 73.0 Fund 59.0 Flow 50.0 Mom 60.0
APVO NASDAQ
Aptevo Therapeutics Inc
Pharmaceutical Preparations
$0.55
-7.68% 1D
Market Cap $1.4M
1M Return -66.14%
1Y Return -62.17%
Forward P/E 3.9x
Unified AI Score
36.9 / 100 SELL
Tech 25.0 Fund 35.0 Flow 50.0 Mom 30.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AADR -9.72% APVO -62.17% Spread: +54.29 pp (AADR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AADR TTM Op. Margin: N/A APVO TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AADR vs APVO. Trailing 12-month operating profitability (AADR N/A vs APVO 0.0%) and valuation multiples (AADR N/M vs APVO 3.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AADR (3) vs APVO (7)
Institutional Metric AADR APVO Criterion Row Winner
Market Capitalization Scale N/A $1.4M Larger Scale APVO
Trailing P/E Ratio Valuation N/M 0.0x Lower Multiple APVO
Forward P/E Ratio Valuation N/M 3.9x Lower Multiple APVO
Revenue Growth (YoY) Growth N/A -100.0% Higher Growth APVO
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin APVO
Net Profit Margin Profitability N/A 0.0% Higher Margin APVO
Return on Equity (ROE) Capital Efficiency N/A -420.3% Higher ROE APVO
52-Week Range Position Momentum 6% ($77โ€“$98) 0% ($0โ€“$11) Stronger Trend AADR
Beta / 30D Volatility Risk Regime 1.12ฮฒ ยท 23% Vol 0.29ฮฒ ยท 122% Vol Lower Realized Risk AADR
Unified Institutional Score Composite Signal 57.7 / 100 (HOLD) 36.9 / 100 (SELL) Higher Composite AADR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AADR vs APVO Buy Guide
AADR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AADR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
APVO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live APVO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AADR nor APVO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.